The INTERLACE trial has revealed that adding short-course induction chemotherapy to chemoradiotherapy significantly improves ...

To facilitate further research, the EMBL team released the Microbial Load Predictor (MLP) tool, which is freely available for ...

Isabel A Hujoel, University of Washington, USA, explained that given the known potential of ARBs to cause enteropathy ...

Discover a study where findings suggest that priority should be placed on identifying and managing autoimmune and ...

VR/AR headsets could one day match desktops in diagnostic effectiveness, according to a recent study. Read more.

Discover how machine learning predicts successful discontinuation of renal therapy in critically ill patients with acute ...

Discover how inebilizumab reduces flares and improves remission rates in IgG4-related disease in this phase 3 clinical trial.

Average rating / 5. Vote count: No votes so far! Be the first to rate this content.

As the year barrels toward its finish, pharmaceutical marketers and medical affairs teams find themselves faced with familiar decision: how to allocate their remaining budget for maximum impact. The ...

Companies the world over are searching for the best ways to implement AI into their systems, and according to a new report from S&P Global, budgets will continue to be driven into this area. The ...

What drew you into the field of RNA? I remember reading the first articles about non-coding RNAs right as I was starting my PhD and being amazed by the versatility of these molecules. RNAs can encode ...

Explore the latest insights into the multifaceted aspects of prostate cancer (PCa) treatment presented at the 2024 European Association of Urology (EAU) Congress in Paris, France. The session delved ...